Tidepath

Melanocortin peptides

Afamelanotide

Also called Scenesse, Melanotan I

An approved implant that darkens skin, for a condition that makes sunlight painful.

Status
Approved by the FDA, as Scenesse, an implant placed by a clinician.
How it's taken
As an implant a healthcare professional places under the skin
Where doses come from
Doses on the label
Half-life
Approximately 15 hours

What it is

Afamelanotide is a lab-made, modified form (an analogue) of alpha-MSH, a hormone that drives skin color. Under the brand name SCENESSE, it's a 16 mg implant that a healthcare professional places under the skin every two months. It's approved to let adults who have had painful reactions to light from erythropoietic protoporphyria (EPP) spend more time in light without pain. EPP is an inherited condition in which sunlight causes pain.

What makes it distinct

It darkens skin, an effect Melanotan II is discussed for, and it has an FDA label, measured data on how long it lasts in the body, and a stated use behind it. The catch is what the label is for, a rare genetic condition that makes sunlight painful, and that it's a prescription implant the label says a healthcare professional should insert.

Doses on the label

16 mg, and only 16 mg. It's an implant with one fixed strength, not a dose you adjust up or down (titrate), so the top and bottom of the range are the same number. One implant every two months, per the label. A healthcare professional places it, and Tidepath doesn't track it yet.

Source FDA label for Scenesse. Checked 3 Sep 2026.

This describes the source. It isn't advice.

Open questions

  • How long treatment should go on. The label gives no yearly maximum, and two of the trials behind it gave three implants over 180 days and five over 270.
  • What it does outside its approved use. The label describes no cosmetic or tanning use, and the three clinical trials on its label were in people with EPP.
  • How the skin darkening it causes compares with what Melanotan II does to skin. Nothing in our sources compares them.

Worth knowing

Its label warns of serious allergic reactions (hypersensitivity), including anaphylaxis, and says it may darken existing moles and freckles. It recommends a full-body skin check twice a year.

More in Melanocortin peptides